|
| 37579872 | The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission. | J Cardiol | 2024 |
| 38073038 | Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects. | J Am Soc Nephrol | 2024 |
| 36254693 | Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. | Eur Heart J | 2023 |
| 37916156 | Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer. | Front Oncol | 2023 |
| 38074646 | Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes. | Front Oncol | 2023 |
| 37752063 | Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19. | Influenza Other Respir Viruses | 2023 |
| 37791195 | Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT). | Cureus | 2023 |
| 37649316 | Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry. | ESC Heart Fail | 2023 |
| 37540060 | Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE. | Eur J Heart Fail | 2023 |
| 37678961 | Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry. | JACC Heart Fail | 2023 |
| 37973338 | Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. | Lancet Glob Health | 2023 |
| 37218619 | Comparison of pulmonary congestion severity using artificial intelligence-assisted scoring versus clinical experts: A secondary analysis of BLUSHED-AHF. | Eur J Heart Fail | 2023 |
| 37312239 | Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. | Eur J Heart Fail | 2023 |
| 36974770 | Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. | Eur J Heart Fail | 2023 |
| 37038330 | The win ratio method in heart failure trials: lessons learnt from EMPULSE. | Eur J Heart Fail | 2023 |
| 36623969 | Medication Discussions With Patients With Cardiovascular Disease in the Emergency Department: An Opportunity for Emergency Nurses to Engage Patients to Support Medication Reconciliation. | J Emerg Nurs | 2023 |
| 36520547 | Emergency physician risk tolerance in acute heart failure is higher than previously thought and compatible with modern disposition decision instruments. | Acad Emerg Med | 2023 |
| 36682681 | Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ). | Int J Infect Dis | 2023 |
| 36826994 | Dosimetric predictors of acute bowel toxicity after Stereotactic Body Radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. | Acta Oncol | 2023 |
| 36896716 | In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility. | Circ Heart Fail | 2023 |
| 36196060 | Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. | Eur J Heart Fail | 2023 |
| 34620774 | Multicenter social media community consultation for an exception from informed consent trial of the XStat device (PhoXStat trial). | J Trauma Acute Care Surg | 2022 |
| 35774493 | Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons. | Int J Part Ther | 2022 |
| 35710817 | Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks. | Sci Rep | 2022 |
| 35709825 | Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19. | Lancet Respir Med | 2022 |
| 35649474 | Current Emergency Department Disposition of Patients With Acute Heart Failure: An Opportunity for Improvement. | J Card Fail | 2022 |
| 35377706 | Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. | Circulation | 2022 |
| 35504307 | Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia. | Chest | 2022 |
| 35402242 | Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer. | Front Oncol | 2022 |
| 35433457 | Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer. | Front Oncol | 2022 |
| 35366926 | Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI. | Radiat Oncol | 2022 |
| 35393622 | Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction. | Eur Heart J | 2022 |
| 35714039 | Prostate MRI in Stereotactic Body Radiation Treatment Planning and Delivery for Localized Prostate Cancer. | Radiographics | 2022 |
| 36620537 | Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer. | Front Oncol | 2022 |
| 36111511 | Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas. | ESC Heart Fail | 2022 |
| 35933224 | Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies). | Am J Cardiol | 2022 |
| 36204696 | Novel machine learning models to predict endocrine disruption activity for high-throughput chemical screening. | Front Toxicol | 2022 |
| 36066557 | Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial. | Eur J Heart Fail | 2022 |
| 35127506 | Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer. | Front Oncol | 2022 |
| 35096594 | Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy. | Front Oncol | 2022 |
| 35064730 | Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry. | Eur J Heart Fail | 2022 |
| 35305936 | Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer. | J Sex Med | 2022 |
| 35228754 | The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. | Nat Med | 2022 |
| 34516969 | A global perspective of racial differences and outcomes in patients presenting with acute heart failure. | Am Heart J | 2022 |
| 34836735 | Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. | Clin Oncol (R Coll Radiol) | 2022 |
| 34774650 | Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. | Radiother Oncol | 2022 |
| 32667101 | Does end-organ dysfunction precede or follow cardiogenic shock in acute decompensated heart failure? The two-faced Janus. Reply. | Eur J Heart Fail | 2021 |
| 33718117 | Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer. | Front Oncol | 2021 |
| 33493615 | Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. | Int J Radiat Oncol Biol Phys | 2021 |
| 33573739 | Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure. | J Am Coll Cardiol | 2021 |